APA-referens

Bähr, O., Tabatabai, G., Fietkau, R., Goldbrunner, R., & Glas, M. G. (2019). P14.63 The use of TTFields for newly diagnosed GBM patients in Germany in routine clinical care (TIGER: TTFields in Germany in routine clinical care). Neuro Oncol.

Chicago-stil citat

Bähr, O., G. Tabatabai, R. Fietkau, R. Goldbrunner, och M G. Glas. "P14.63 The Use of TTFields for Newly Diagnosed GBM Patients in Germany in Routine Clinical Care (TIGER: TTFields in Germany in Routine Clinical Care)." Neuro Oncol 2019.

MLA-referens

Bähr, O., et al. "P14.63 The Use of TTFields for Newly Diagnosed GBM Patients in Germany in Routine Clinical Care (TIGER: TTFields in Germany in Routine Clinical Care)." Neuro Oncol 2019.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.